The research team is led by Professor Anders Kvanta and Dr Helder André, with a research portfolio to provide unpreceded cellular and molecular mechanistic views on neovascular and degenerative retinal diseases, with high focus on translational sustainable therapy strategies for patients with blinding diseases.
The Kvanta/André group conducts translational studies focused on identifying and improving treatments of several retinal diseases, including retinal degenerations, retinal vein occlusion and diabetic retinopathy. The key area of our current research is age-related macular degeneration (AMD), one of the most common and rapidly increasing sight-threatening diseases. Advanced AMD is a major cause of severe central vision loss affecting more than 180 million people globally (over 100,000 in Sweden). Despite a seemingly low incidence, AMD has one the of fastest rates of increased prevalence in the developed world as a consequence of an aging population, and is estimated to become an immense burden for healthcare systems worldwide, with massive economic implications. Due to the protracted nature of AMD, the multifactorial mechanisms involved, and current therapeutic limitations there is a great need for long-term therapies that can regenerate lost retinal cells or mitigate multiple angiogenic and inflammatory factors known to be associated with AMD, simultaneously allowing for sustainable treatments.
The common goal of the Kvanta/André Lab is to develop new treatments for neovascular and degenerative retinal disease. Our experimental projects include molecular and cell biology studies, and preclinical animal models aimed to identify new molecules and pathways relevant to the onset of neovascularization and cell death for these retinal conditions. In addition, preclinical studies are ongoing with gene therapy to treat vascular retinal diseases. Our previous and ongoing research has contributed to the successful development of break-through treatments for wet (neovascular) AMD and has laid the ground for regenerative treatment of dry (degenerative) AMD using human embryonic stem cell (hESC)-derived retinal pigment epithelial cells (RPE).
- Mechanistic and therapeutic studies on ocular vascular diseases
- Sustainable gene therapy for neovascular AMD
- Bench-to-bedside cellular regenerative treatments of dry AMD
- A platform for cellular regenerative treatments of retinal diseases
- A preclinical bioengineering approach for the treatment of Diabetes
Flavia Plastino, Álvaro Santana-Garrido, Noemi Anna Pesce, Monica Aronsson, Emma Lardner, Alfonso Mate, Anders Kvanta, Carmen Maria Vázquez, Helder André
Exp Eye Res. 2021 Feb 25;206:108518.doi: 10.1016/j.exer.2021.108518. Online ahead of print.
Alvaro Plaza Reyes, Sandra Petrus-Reurer, Sara Padrell Sánchez, Pankaj Kumar, Iyadh Douagi, Hammurabi Bartuma, Monica Aronsson, Sofie Westman, Emma Lardner, Helder André, Anna Falk, Emeline F Nandrot, Anders Kvanta, Fredrik Lanner
Nat Commun. 2020 Mar 30;11(1):1609.doi: 10.1038/s41467-020-15326-5.
Sandra Petrus-Reurer, Nerges Winblad, Pankaj Kumar, Laia Gorchs, Michael Chrobok, Arnika Kathleen Wagner, Hammurabi Bartuma, Emma Lardner, Monica Aronsson, Álvaro Plaza Reyes, Helder André, Evren Alici, Helen Kaipe, Anders Kvanta, Fredrik Lanner
Stem Cell Reports. 2020 Apr 14;14(4):648-662.doi: 10.1016/j.stemcr.2020.02.006. Epub 2020 Mar 19.
Filippo Locri, Noemi A Pesce, Monica Aronsson, Maurizio Cammalleri, Mario De Rosa, Vincenzo Pavone, Paola Bagnoli, Anders Kvanta, Massimo Dal Monte, Helder André
J Mol Med (Berl). 2020 Nov;98(11):1629-1638.doi: 10.1007/s00109-020-01979-8. Epub 2020 Sep 17.
Parviz Mammadzada, Juliette Bayle, Johann Gudmundsson, Anders Kvanta, Helder André
J Clin Med. 2019 Dec 15;8(12):2217.doi: 10.3390/jcm8122217.
Anna Takei, Malena Ekström, Parviz Mammadzada, Monica Aronsson, Ma Yu, Anders Kvanta, Helder André
Sci Rep. 2017 Feb 10;7:42546.doi: 10.1038/srep42546.
Anders Kvanta, Manuel Casselholm de Salles, Urban Amrén, Hammurabi Bartuma
Observational Study Retina. 2017 May;37(5):936-942.doi: 10.1097/IAE.0000000000001248.
Alvaro Plaza Reyes, Sandra Petrus-Reurer, Liselotte Antonsson, Sonya Stenfelt, Hammurabi Bartuma, Sarita Panula, Theresa Mader, Iyadh Douagi, Helder André, Outi Hovatta, Fredrik Lanner, Anders Kvanta
Stem Cell Reports. 2016 Jan 12;6(1):9-17.doi: 10.1016/j.stemcr.2015.11.008. Epub 2015 Dec 24.
Helder André, Selcuk Tunik, Monica Aronsson, Anders Kvanta
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6591-604.doi: 10.1167/iovs.15-16476.
David L J Epstein, Peep V Algvere, Gunvor von Wendt, Stefan Seregard, Anders Kvanta
Ophthalmology. 2012 Jun;119(6):1184-9.doi: 10.1016/j.ophtha.2012.01.022. Epub 2012 Mar 17.
Anne-Catherine Söderberg, Peep V Algvere, Jürg C Hengstler, Pär Söderberg, Stefan Seregard, Anders Kvanta
Br J Ophthalmol. 2012 May;96(5):714-8.doi: 10.1136/bjophthalmol-2011-300721. Epub 2012 Jan 12.
Witold W Kilarski 1 , Branka Samolov, Ludvig Petersson, Anders Kvanta, Pär Gerwins
Nat Med. 2009 Jun;15(6):657-64.doi: 10.1038/nm.1985.
A Kvanta, P V Algvere, L Berglin, S Seregard
Invest Ophthalmol Vis Sci. 1996 Aug;37(9):1929-34.
Selçuk Tunik, Associate Professor at University of Dicle, Turkey
Effat Alizadeh, Associate Professor at Tabriz University of Medical Sciences, Iran
Jóhann Gu∂mundsson, Head of Ophthalmology at Lanspitali, Iceland
Sandra Petrus-Reurer, Postdoc at Cambridge University, UK
Parviz Mammadzada, MD Ophthalmology Specialist at Örebro hospital, Sweden
·Novo Nordisk Collaborative support
·The ARMEC Lindberg Foundation
·The Swedish Eye Foundation
·The Crown Princess Margareta Association for the Visually Impaired
·The Edwin Jordan Foundation
·KI Foundations and Funds
Support our research
In balance with St. Erik Eye Hospital, the Kvanta/André lab thrives to be able to treat and cure all existing eye diseases. Help by investing in better vision in the future.
Interested in joining the Kvanta/André Lab?
Applications for PhD candidate and postdoc positions are very welcomed from applicants with financing. We also encourage early contacts to plan applications for external personal grants.